Latest News about DNLI
Recent news which mentions DNLI
   What Happened To Denali Therapeutics Stock Wednesday?
   
  
  
  April 02, 2025
  From Benzinga
 
   Denali Therapeutics Ends ALS Trial Extension, Analyst Stays Optimistic Despite Trial Setback
   
  
  
  March 06, 2025
  From Benzinga
 
   Why Is Denali Therapeutics Stock Trading Higher On Wednesday?
   
  
  
  January 15, 2025
  From Benzinga
 
   Denali Therapeutics' Amyotrophic Lateral Sclerosis Misses Pivotal Trial, But Analyst Says It Was Expected
   
  
  
  January 07, 2025
  From Benzinga
 From Benzinga
 
   This Denali Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Friday
   
  
  
  January 03, 2025
  From Benzinga
 
   Denali Therapeutics Stock Is Sliding After The Bell: Here's Why
   
  
  
  October 10, 2024
  From Benzinga
 
   DNLI Stock Earnings: Denali Therapeutics Beats EPS for Q2 2024
   
  August 01, 2024
  Tickers 
   DNLI
  
  
  From InvestorPlace
 
   3 Longevity Stocks to Buy for Anti-Aging Breakthroughs
   
  
  
  July 08, 2024
  From InvestorPlace
 
   Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday
   
  
  
  June 03, 2024
  From Benzinga
 From Benzinga
 Tickers 
   DNLI
  
  
  From InvestorPlace
 
   To the Moon and Beyond: 7 Stocks With Cosmic Potential
   
  
  
  March 14, 2024
  From InvestorPlace
 
   Goldman Sachs Maintains Buy Rating for Denali Therapeutics: Here's What You Need To Know
   
  February 29, 2024
  Tickers 
   DNLI
  
  
  From Benzinga
 
   4 Analysts Assess Denali Therapeutics: What You Need To Know
   
  February 28, 2024
  Tickers 
   DNLI
  
  
  From Benzinga
 
   Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
   
  
  
  February 27, 2024
  From Benzinga
 
   Norwegian Cruise Line Posts Strong Sales, Joins Hims & Hers Health, Sterling Infrastructure And Other Big Stocks Moving Higher On Tuesday
   
  
  
  February 27, 2024
  From Benzinga
 
   Gene Therapy Player REGENXBIO's RGX-121 Marks Success In Trial, Yet Faces Challenges In A Crowded Market: Analyst
   
  
  
  February 12, 2024
  From Benzinga
 
   3 Biotech Stocks to Buy for the Next Bull Run: February 2024
   
  
  
  February 08, 2024
  From InvestorPlace
 
   3 Biotech Stocks at the Forefront of the Quest for Eternal Youth
   
  
  
  January 02, 2024
  From InvestorPlace
 
   Expedia Group, Gartner, Cloudflare, Cardinal Health And Other Big Stocks Moving Higher On Friday
   
  
  
  November 03, 2023
  From Benzinga
 
   Denali Therapeutics Breakthrough Blood-Brain Barrier Platform A Game-Changer in Neurodegenerative Diseases: Analyst
   
  
  
  September 06, 2023
  From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023
   
  
  
  September 06, 2023
  From Benzinga
 From InvestorPlace
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
